Furaltadone metabolite (CPAMOZ) antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Furaltadone metabolite (CPAMOZ) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to food safety diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-80-11. BSA-Furaltadone metabolite (CPAMOZ)
2. Anti-Furaltadone metabolite (CPAMOZ) mouse monoclonal antibody
$2709.00
GMP-SMT-80-21. OVA-Furaltadone metabolite (CPAMOZ)
2. Anti-Furaltadone metabolite (CPAMOZ) mouse monoclonal antibody
$2709.00
GMP-SMT-80-31. BSA-Furaltadone metabolite (CPAMOZ)
2. Anti-Furaltadone metabolite (CPAMOZ) human monoclonal antibody
$2709.00
GMP-SMT-80-41. OVA-Furaltadone metabolite (CPAMOZ)
2. Anti-Furaltadone metabolite (CPAMOZ) human monoclonal antibody
$2709.00
GMP-SMT-80-Ag-1BSA-Furaltadone metabolite (CPAMOZ)$756.00
GMP-SMT-80-Ag-2OVA-Furaltadone metabolite (CPAMOZ)$756.00
GMP-SMT-80-Ab-1Anti-Furaltadone metabolite (CPAMOZ) mouse monoclonal antibody$1953.00
GMP-SMT-80-Ab-2Anti-Furaltadone metabolite (CPAMOZ) human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Furaltadone metabolite (CPAMOZ)

Cat No.GMP-SMT-80-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Furaltadone metabolite (CPAMOZ) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Furaltadone metabolite (CPAMOZ) had been validated with our anti-Hapten antibody Anti-Furaltadone metabolite (CPAMOZ) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Furaltadone metabolite (CPAMOZ)

Cat No.GMP-SMT-80-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Furaltadone metabolite (CPAMOZ) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Furaltadone metabolite (CPAMOZ) had been validated with our anti-Hapten antibody Anti-Furaltadone metabolite (CPAMOZ) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Furaltadone metabolite (CPAMOZ) mouse monoclonal antibody

Cat No.GMP-SMT-80-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.30
Products descriptionThe anti-Hapten antibody against hapten Furaltadone metabolite (CPAMOZ) had been validated with our hapten hapten-carrier conjugates BSA-Furaltadone metabolite (CPAMOZ) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Furaltadone metabolite (CPAMOZ) human monoclonal antibody

Cat No.GMP-SMT-80-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.30
Products descriptionThe anti-Hapten antibody against hapten Furaltadone metabolite (CPAMOZ) had been validated with our hapten hapten-carrier conjugates BSA-Furaltadone metabolite (CPAMOZ) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Biomarker Information


    Basic Orange (BO/CSD) is a type of basic dye that belongs to the xanthene family. It is commonly used in various industrial sectors, including textiles, paper manufacturing, and plastic production, as a coloring agent. BO/CSD's chemical structure consists of a pyridine ring and an amino group (-NH2), with variations in the substituents attached to the pyridine ring affecting its properties and applications.

    BO/CSD's widespread usage has raised concerns about its potential risks to the environment and human health. The dye can enter the environment through various pathways, such as wastewater discharges from industrial facilities, leaching from landfills where waste containing BO/CSD is disposed of, or accidental spills during transportation or handling. Once released, BO/CSD can contaminate water bodies, soil, and sediments, leading to potential environmental and ecological consequences.

    One of the primary concerns regarding BO/CSD is its environmental persistence and resistance to degradation. The dye has been found to remain in the environment for extended periods without significant breakdown, which increases the likelihood of accumulation in different environmental compartments. This persistence raises concerns about its long-term impact on ecosystems and the potential for it to enter the food chain.

    Studies have indicated that BO/CSD can have toxic effects on aquatic organisms. When exposed to BO/CSD, fish, algae, and other aquatic species can experience changes in their behavior, growth, and reproductive capabilities. The dye's presence in surface water can disrupt the aquatic ecosystem, potentially leading to a cascade of adverse impacts on other organisms within the food chain.

    Furthermore, BO/CSD's release into the environment can pose risks to human health. Prolonged exposure to BO/CSD has been associated with skin irritation, respiratory issues, and other health problems. It is also worth noting that the breakdown products of BO/CSD in the environment can be more toxic than the original dye itself, further increasing potential health risks.

    To address these concerns, monitoring the levels of BO/CSD in the environment is critical for assessing potential risks to human health and ecosystems. Regular monitoring of BO/CSD levels in surface water, sediment, and biota helps identify pollution sources and implement measures to minimize its inputs into the environment. Analyzing BO/CSD concentrations aids in identifying trends, evaluating the effectiveness of pollution control measures, and promoting sustainable practices.

    Various analytical techniques are available for detecting and quantifying BO/CSD concentrations in environmental samples. Fluorescence spectroscopy is commonly used due to its sensitivity and selectivity in detecting fluorescent compounds like BO/CSD. Spectrophotometry, including absorption and emission measurements, can provide rapid and cost-effective analysis of BO/CSD levels. High-performance liquid chromatography (HPLC) is another widely used technique that offers accurate and precise measurements of BO/CSD concentrations in complex environmental matrices.

    In conclusion, Basic Orange (BO/CSD) is an extensively used industrial dye that raises concerns about its potential impact on human health and the environment. Ongoing monitoring of BO/CSD levels in environmental samples is crucial for identifying pollution sources, tracking contamination trends, and developing effective management strategies to minimize potential risks. Analytical techniques play a vital role in quantifying BO/CSD concentrations and providing critical information to regulatory agencies and stakeholders to safeguard public health and preserve the integrity of ecosystems. Implementing sustainable practices, improving wastewater treatment technologies, and promoting the development and use of safer alternatives can help reduce the potential risks associated with BO/CSD and other hazardous dyes, fostering a more environmentally sustainable future.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.